Market Overview:
The global collagen stimulant market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for collagen stimulants for aesthetic applications such as sculptra and ellanse. In addition, the growing awareness about the benefits of collagen stimulants is also contributing to the growth of this market. The global collagen stimulator market is segmented on the basis of type, application and region. On the basis of type, it is divided into no license and class III medical equipment. Class III medical equipment held a major share in 2017 owing to its high efficacy and safety standards as compared to no license products. On the basis of application, it is divided into sculptra, ellanse and other applications such as dermal fillers etcetera . Sculptra held a major share in 2017 owing to its ability to provide long-term results with a single treatment session.
Product Definition:
A collagen stimulant is a substance that helps to increase the production of collagen in the skin. Collagen is responsible for maintaining the structure and elasticity of the skin, so increasing its production can help to reduce wrinkles and other signs of aging.
No License:
No license is a term used in the medical industry which means there is no formal training or education required to practice medicine. In layman terms, it means that any person with an adequate knowledge of anatomy and physiology can call themselves a physician and start practicing. However, this title does not automatically mean that one has expertise in all fields of medicine.
Class â… Medical Equipment:
The global collagen stimulant market is expected to witness significant growth over the forecast period. The market growth can be attributed to factors such as increasing geriatric population base, rising prevalence of arthritis and osteoporosis coupled with an increase in consumer awareness regarding the benefits of these drugs.
Application Insights:
The use of collagen stimulants is approved for the treatment of Sculptra, Ellanse and Restylane. The Sculptra application segment accounted for a revenue share of around 40% in 2017. It is used to treat wrinkles and loss of volume in the face as well as neck region. The product helps enhance skin¢â‚¬â„¢s appearance by improving its texture and reducing fine lines, wrinkles, sagging skin & bags under eyes caused due to aging or any other reason.
The Ellanse application segment is expected to witness the fastest growth over the forecast period owing to increasing demand from emerging economies such as India, China Japan etcetera regarding injectable fillers for liposuction procedures that are gaining popularity across these regions.
Regional Analysis:
North America held the largest revenue share of around 40% in 2017. The region is expected to maintain its dominance throughout the forecast period owing to high awareness levels regarding osteoporosis treatment options, increasing geriatric population prone to bone fragility, and presence of well-established healthcare facilities in the region. In addition, rising demand for minimally invasive surgeries and technological advancements such as X-ray imaging and computed radiography are also contributing towards market growth in this region.
Asia Pacific is anticipated to be one of the fastest growing regions over the forecast period owing to rising disposable income levels coupled with improving healthcare infrastructure especially in developing countries such as China & India which are major contributors towards regional growth.
Growth Factors:
- Increasing awareness about the benefits of collagen stimulant products among consumers.
- Rising demand for anti-aging products and therapies.
- Growing popularity of natural ingredients in skin care products.
- increasing disposable income and spending on luxury skin care products by the younger generation .
Scope Of The Report
Report Attributes
Report Details
Report Title
Collagen Stimulant Market Research Report
By Type
No License, Class Ⅰ Medical Equipment, Class III Medical Equipment
By Application
Sculptra, Ellanse
By Companies
IMEIK, Changchun SinoBiomaterials, Changchun Foliaplast Bio-Tech, Coronado Medical, Zhejiang Wedu Medical, GANA Biopharmaceutical, ELASTEM, Galderma, Regen Biotech, Anteco Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Collagen Stimulant Market Report Segments:
The global Collagen Stimulant market is segmented on the basis of:
Types
No License, Class Ⅰ Medical Equipment, Class III Medical Equipment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Sculptra, Ellanse
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IMEIK
- Changchun SinoBiomaterials
- Changchun Foliaplast Bio-Tech
- Coronado Medical
- Zhejiang Wedu Medical
- GANA Biopharmaceutical
- ELASTEM
- Galderma
- Regen Biotech
- Anteco Pharma
Highlights of The Collagen Stimulant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- No License
- Class Ⅰ Medical Equipment
- Class III Medical Equipment
- By Application:
- Sculptra
- Ellanse
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Collagen Stimulant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Collagen stimulant is a type of supplement that claims to increase the production of collagen in the body. Collagen is a protein found in skin, bones, and other tissues in the body.
Some of the key players operating in the collagen stimulant market are IMEIK, Changchun SinoBiomaterials, Changchun Foliaplast Bio-Tech, Coronado Medical, Zhejiang Wedu Medical, GANA Biopharmaceutical, ELASTEM, Galderma, Regen Biotech, Anteco Pharma.
The collagen stimulant market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Collagen Stimulant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Collagen Stimulant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Collagen Stimulant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Collagen Stimulant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Collagen Stimulant Market Size & Forecast, 2018-2028
4.5.1 Collagen Stimulant Market Size and Y-o-Y Growth
4.5.2 Collagen Stimulant Market Absolute $ Opportunity
Chapter 5 Global Collagen Stimulant Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Collagen Stimulant Market Size Forecast by Type
5.2.1 No License
5.2.2 Class Ⅰ Medical Equipment
5.2.3 Class III Medical Equipment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Collagen Stimulant Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Collagen Stimulant Market Size Forecast by Applications
6.2.1 Sculptra
6.2.2 Ellanse
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Collagen Stimulant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Collagen Stimulant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Collagen Stimulant Analysis and Forecast
9.1 Introduction
9.2 North America Collagen Stimulant Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Collagen Stimulant Market Size Forecast by Type
9.6.1 No License
9.6.2 Class Ⅰ Medical Equipment
9.6.3 Class III Medical Equipment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Collagen Stimulant Market Size Forecast by Applications
9.10.1 Sculptra
9.10.2 Ellanse
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Collagen Stimulant Analysis and Forecast
10.1 Introduction
10.2 Europe Collagen Stimulant Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Collagen Stimulant Market Size Forecast by Type
10.6.1 No License
10.6.2 Class Ⅰ Medical Equipment
10.6.3 Class III Medical Equipment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Collagen Stimulant Market Size Forecast by Applications
10.10.1 Sculptra
10.10.2 Ellanse
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Collagen Stimulant Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Collagen Stimulant Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Collagen Stimulant Market Size Forecast by Type
11.6.1 No License
11.6.2 Class Ⅰ Medical Equipment
11.6.3 Class III Medical Equipment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Collagen Stimulant Market Size Forecast by Applications
11.10.1 Sculptra
11.10.2 Ellanse
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Collagen Stimulant Analysis and Forecast
12.1 Introduction
12.2 Latin America Collagen Stimulant Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Collagen Stimulant Market Size Forecast by Type
12.6.1 No License
12.6.2 Class Ⅰ Medical Equipment
12.6.3 Class III Medical Equipment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Collagen Stimulant Market Size Forecast by Applications
12.10.1 Sculptra
12.10.2 Ellanse
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Collagen Stimulant Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Collagen Stimulant Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Collagen Stimulant Market Size Forecast by Type
13.6.1 No License
13.6.2 Class Ⅰ Medical Equipment
13.6.3 Class III Medical Equipment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Collagen Stimulant Market Size Forecast by Applications
13.10.1 Sculptra
13.10.2 Ellanse
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Collagen Stimulant Market: Competitive Dashboard
14.2 Global Collagen Stimulant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 IMEIK
14.3.2 Changchun SinoBiomaterials
14.3.3 Changchun Foliaplast Bio-Tech
14.3.4 Coronado Medical
14.3.5 Zhejiang Wedu Medical
14.3.6 GANA Biopharmaceutical
14.3.7 ELASTEM
14.3.8 Galderma
14.3.9 Regen Biotech
14.3.10 Anteco Pharma
